Tests
CSF Leukocyte Count
The number of leukocytes in the cerebrospinal fluid sample.
Loading
Loading
Search products, companies, tests, and guides — go from query to quote request in one place.
Tests
The number of leukocytes in the cerebrospinal fluid sample.
Tests
The determination of the amount of degenerated leukocytes (leukocytes that show deterioration in form or function) present in a sample.
Tests
The determination of the ratio of dendritic cells to leukocytes present in a sample. The measurement may be expressed as a ratio or percentage.
Tests
The determination of the ratio of dendritic cells to leukocytes that are not T cells, B cells or natural killer cells present in a sample. The measurement may be expressed as a ratio or percentage.
Tests
A hematologic procedure for the evaluation of the qualitative and quantitative characteristics of the white cells in peripheral blood smears and bone marrow aspirates.
Tests
The determination of the ratio of granulocytes to the non-classical monocytes to all leukocytes that are not T-cells, B-cells, or natural killer cells, present in a sample. The measurement may be expressed as a ratio or percentage.
Tests
The determination of the ratio of hairy cells (B-cell lymphocytes with hairy projections from the cytoplasm) compared to all leukocytes present in a sample. The measurement may be expressed as a ratio or percentage.
Tests
The determination of the ratio of the helper T-lymphocytes to leukocytes present in a sample. The measurement may be expressed as a ratio or percentage.
Tests
The determination of the number of mismatch between the study subject and his or her donor for the human leukocyte antigen, class I, group A (HLA-A).
Tests
The determination of the number of mismatch between the study subject and his or her donor for the human leukocyte antigen, class I, group B (HLA-B).
Tests
The determination of the ratio of the human leukocyte antigen DR (HLA-DR) to leukocytes present in a sample. The measurement may be expressed as a ratio or percentage.
Tests
The determination of the ratio of the human leukocyte antigen DR (HLA-DR) to total cells present in a sample. The measurement may be expressed as a ratio or percentage.